Compare ACON & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACON | DSS |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 7.0M |
| IPO Year | 2022 | 2020 |
| Metric | ACON | DSS |
|---|---|---|
| Price | $1.99 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.7K | 25.8K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | 42.45 |
| EPS | ★ N/A | N/A |
| Revenue | $75,730.00 | ★ $2,085,000.00 |
| Revenue This Year | $44.55 | N/A |
| Revenue Next Year | $123.97 | $43.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.62 | N/A |
| 52 Week Low | $1.85 | $0.36 |
| 52 Week High | $9.36 | $1.86 |
| Indicator | ACON | DSS |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 32.77 |
| Support Level | N/A | $0.49 |
| Resistance Level | $3.54 | $0.58 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 15.18 | 11.14 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.